Pseudomonas aeruginosa is an opportunistic pathogen that causes health care-associated infections. The rise of antibiotic-resistant bacterial strains necessitates alternative treatment strategies, with bacteriophage therapy being a promising approach.
Methods:
Six bacteriophages were isolated from sewage samples. Phage isolation involved centrifugation, filtration, and plaque assays. The morphology of each sample was examined using transmission electron microscopy (TEM). Genomic DNA was sequenced and compared among the isolates. The phages’ lytic activities were assessed using growth curve analysis.
Results:
The phages displayed distinct genomic characteristics, grouping into three genomic clusters. No known virulence or antibiotic resistance genes were detected, indicating their safety for therapeutic use. Taxonomic analysis identified the phages as belonging to the genera Pbunavirus, Nipunavirus, Abidjanvirus, and a novel genus. TEM analysis revealed their diverse morphologies. Temperate phages showed less effective lytic activities.
Conclusion:
Several of the isolated bacteriophages show potential as candidates for phage therapy research and could be effective against P. aeruginosa infections.
Get full access to this article
View all access options for this article.
References
1.
GellatlySL, HancockREW. Pseudomonas aeruginosa: New insights into pathogenesis and host defenses. Pathog Dis, 2013; 67(3):159–173.
2.
Nir-PazR, GelmanD, KhouriA, et al.Successful treatment of antibiotic-resistant, poly-microbial bone infection with bacteriophages and antibiotics combination. Clin Infect Dis, 2019; 69(11):2015–2018.
3.
OnallahH, HazanR, Nir-PazR, et al.;PASA16 study group. Refractory Pseudomonas aeruginosa infections treated with phage PASA16: A compassionate use case series. Med, 2023; 4(9):600–611.e4.
4.
SalmondGPC, FineranPC. A century of the phage: Past, present and future. Nat Rev Microbiol, 2015; 13(12):777–786.
5.
CheginiZ, KhoshbayanA, Taati MoghadamM, et al.Bacteriophage therapy against Pseudomonas aeruginosa biofilms: A review. Ann Clin Microbiol Antimicrob, 2020; 19:1–45.
6.
PheeA, Bondy-DenomyJ, KishenA, et al.Efficacy of bacteriophage treatment on Pseudomonas aeruginosa biofilms. J Endod, 2013; 39(3):364–369.
7.
BraunsteinR, HubanicG, YerushalmyO, et al.Successful phage-antibiotic therapy of P. aeruginosa implant-associated infection in a Siamese cat. Vet Q, 2024; 44(1):1–9.
8.
YerushalmyO, KhalifaL, GoldN, et al.The Israeli phage bank (IPB). Antibiotics, 2020; 9(5):269.
9.
GraceA, SahuR, OwenDR, et al.Pseudomonas aeruginosa reference strains PAO1 and PA14: A genomic, phenotypic, and therapeutic review. Front Microbiol, 2022; 13:1023523.
10.
RimonA, RakovC, LererV, et al.Topical phage therapy in a mouse model of Cutibacterium acnes-induced acne-like lesions. Nat Commun, 2023; 14(1):1005.
11.
YerushalmyO, BraunsteinR, Alkalay-OrenS, et al.Towards standardization of phage susceptibility testing: The Israeli phage therapy center “Clinical Phage Microbiology”—A Pipeline Proposal. Clin Infect Dis, 2023; 77(Suppl 5):S337–S351.
12.
ArtawinataPC, LorraineS, WaturangiDE. Isolation and characterization of bacteriophages from soil against food spoilage and foodborne pathogenic bacteria. Sci Rep, 2023; 13(1):9282.
13.
NamonyoS, CarvalhoG, GuoJ, et al.Novel bacteriophages show activity against selected Australian clinical strains of Pseudomonas aeruginosa. Microorganisms, 2022; 10(2):210.
14.
PirachaZ, SaeedU, KhurshidA, et al.Isolation and partial characterization of virulent phage specific against Pseudomonas aeruginosa. Glob J Med Res, 2014; 14(1):1–8.
McNairK, ZhouC, DinsdaleEA, et al.PHANOTATE: A novel approach to gene identification in phage genomes. Bioinformatics, 2019; 35(22):4537–4542.
17.
ChanPP, LinBY, MakAJ, et al.tRNAscan-SE 2.0: Improved detection and functional classification of transfer RNA genes. Nucleic Acids Res, 2021; 49(16):9077–9096.
18.
LaslettD, CanbackB. ARAGORN, a program to detect tRNA genes and tmRNA genes in nucleotide sequences. Nucleic Acids Res, 2004; 32(1):11–16.
19.
BlandC, RamseyTL, SabreeF, et al.CRISPR recognition tool (CRT): A tool for automatic detection of clustered regularly interspaced palindromic repeats. BMC Bioinformatics, 2007; 8:209–208.
20.
TerzianP, Olo NdelaE, GaliezC, et al.PHROG: Families of prokaryotic virus proteins clustered using remote homology. NAR Genom Bioinform, 2021; 3(3):lqab067.
21.
ChenL, YangJ, YuJ, et al.VFDB: A reference database for bacterial virulence factors. Nucleic Acids Res, 2005; 33(Database issue):D325–D8.
22.
AlcockBP, RaphenyaAR, LauTTY, et al.CARD 2020: Antibiotic resistome surveillance with the comprehensive antibiotic resistance database. Nucleic Acids Res, 2020; 48(D1):D517–D525.
23.
SteineggerM, SödingJ. MMseqs2 enables sensitive protein sequence searching for the analysis of massive data sets. Nat Biotechnol, 2017; 35(11):1026–1028.
24.
LarraldeM, ZellerG. PyHMMER: A Python library binding to HMMER for efficient sequence analysis. Bioinformatics, 2023; 39(5):btad214.
25.
CookR, BrownN, RedgwellT, et al.INfrastructure for a PHAge REference database: Identification of large-scale biases in the current collection of cultured phage genomes. Phage (New Rochelle), 2021; 2(4):214–223.
26.
OndovBD, TreangenTJ, MelstedP, et al.Mash: Fast genome and metagenome distance estimation using MinHash. Genome Biol, 2016; 17:1–14.
27.
ShangJ, PengC, LiaoH, et al.PhaBOX: A web server for identifying and characterizing phage contigs in metagenomic data. Bioinform Adv, 2023; 3(1):vbad101.
28.
MillardAD, DeniseR, LestidoM, et al.taxmyPHAGE: Automated taxonomy of dsDNA phage genomes at the genus and species. bioRxiv, 2024:2024–2028.
29.
GrantJR, EnnsE, MarinierE, et al.Proksee: In-depth characterization and visualization of bacterial genomes. Nucleic Acids Res, 2023; 51(W1):W484–W492.
30.
MoraruC, VarsaniA, KropinskiAM. VIRIDIC—A novel tool to calculate the intergenomic similarities of prokaryote-infecting viruses. Viruses, 2020; 12(11):1268.
31.
LeeI, Ouk KimY, ParkSC, et al.OrthoANI: an improved algorithm and software for calculating average nucleotide identity. Int J Syst Evol Microbiol, 2016; 66(2):1100–1103.
32.
Bailly-BechetM, VergassolaM, RochaE. Causes for the intriguing presence of tRNAs in phages. Genome Res, 2007; 17(10):1486–1495.
33.
LinaresR, ArnaudCA, DegrouxS, et al.Structure, function and assembly of the long, flexible tail of siphophages. Curr Opin Virol, 2020; 45:34–42.
34.
FeinerR, ArgovT, RabinovichL, et al.A new perspective on lysogeny: Prophages as active regulatory switches of bacteria. Nat Rev Microbiol, 2015; 13(10):641–650.
35.
Guerrero-BustamanteCA, HatfullGF. Bacteriophage tRNA-dependent lysogeny: Requirement of phage-encoded tRNA genes for establishment of lysogeny. mBio, 2024; 15(2):e03260-23.
36.
van den BergDF, van der SteenBA, CostaAR, et al.Phage tRNAs evade tRNA-targeting host defenses through anticodon loop mutations. Elife, 2023; 12:e85183.
37.
Alkalay-OrenS, YerushalmyO, AdlerK, et al.Complete Genome Sequence of Pseudomonas aeruginosa Bacteriophage PASA16, Used in Multiple Phage Therapy Treatments Globally. Microbiol Resour Announc, 2022; 11(4):e00092-22.
38.
FujikiJ, FurusawaT, MunbyM, et al.Susceptibility of Pseudomonas aeruginosa veterinary isolates to Pbunavirus PB1‐like phages. Microbiol Immunol, 2020; 64(11):778–782.
39.
WhiteleyLE, WhiteleyM. Characterization of a new Pseudomonas aeruginosa Queuovirinae bacteriophage. Microbiol Spectr, 2024; 12(3):e03719-23.
40.
MarmoP, ThallerMC, Di LalloG, et al.Characterization of vB_StuS_MMDA13, a newly discovered bacteriophage infecting the agar-degrading species Sphingomonas turrisvirgatae. Viruses, 2020; 12(8):894.
41.
Howard-VaronaC, HargreavesKR, AbedonST, et al.Lysogeny in nature: Mechanisms, impact and ecology of temperate phages. ISME J, 2017; 11(7):1511–1520.
AltamiranoFLG, BarrJJ. Phage therapy in the postantibiotic era. Clin Microbiol Rev, 2019; 32(2).
44.
StrathdeeSA, HatfullGF, MutalikVK, et al.Phage therapy: From biological mechanisms to future directions. Cell [Internet], 2023; 186(1):17–31.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
